Exact Mass: 581.405633
Exact Mass Matches: 581.405633
Found 104 metabolites which its exact mass value is equals to given mass value 581.405633
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
5-O-beta-D-mycaminosyl-20-oxotylonolide
A macrolide antibiotic that is 20-oxotylactone having a 5-O-beta-D-mycaminosyl residue attached at position 6.
Rosamicin
Rosamicin
A macrolide antibiotic with activity against Neisseria gonorrhoeae, Chlamydia trachomatis, Ureaplasma urealyticum and Mycoplasma hominis. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007933 - Leucomycins C784 - Protein Synthesis Inhibitor > C261 - Macrolide Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic Origin: Microbe
Unii-SJ5A8151JO
COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D013501 - Surface-Active Agents > D054709 - Lecithins Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
2-[(2R,3R,7R,8S,9S,10R,12R,14E)-9-[(2R,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-7-hydroxy-2,8,12,16-tetramethyl-5,13-dioxo-4,17-dioxabicyclo[14.1.0]heptadec-14-en-10-yl]acetaldehyde
1-O-hexadecyl-2-(5-hydroxyvaleroyl)-sn-glycero-3-phosphocholine
1-Hexadecyl-2-succinyl-sn-glycero-3-phosphocholine
(4E,8E,12E)-3-hydroxy-2-[[(4Z,7Z)-2-hydroxyhexadeca-4,7-dienoyl]amino]hexadeca-4,8,12-triene-1-sulfonic acid
(4E,8E,12E)-3-hydroxy-2-[[(10Z,12Z)-2-hydroxyoctadeca-10,12-dienoyl]amino]tetradeca-4,8,12-triene-1-sulfonic acid
(4E,8E,12E)-3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]octadeca-4,8,12-triene-1-sulfonic acid
(4E,8E)-3-hydroxy-2-[[(9Z,12Z)-octadeca-9,12-dienoyl]amino]pentadeca-4,8-diene-1-sulfonic acid
(4E,8E,12E)-3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]pentadeca-4,8,12-triene-1-sulfonic acid
(4E,8E,12E)-2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxyhexadeca-4,8,12-triene-1-sulfonic acid
3-hydroxy-2-[[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]amino]pentadecane-1-sulfonic acid
(E)-2-[[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]amino]-3-hydroxyheptadec-4-ene-1-sulfonic acid
(4E,8E)-2-[[(11Z,14Z)-henicosa-11,14-dienoyl]amino]-3-hydroxydodeca-4,8-diene-1-sulfonic acid
(4E,8E)-2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxyheptadeca-4,8-diene-1-sulfonic acid
(E)-2-[[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]amino]-3-hydroxyundec-4-ene-1-sulfonic acid
(4E,8E,12E)-3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]nonadeca-4,8,12-triene-1-sulfonic acid
(4E,8E)-3-hydroxy-2-[[(9Z,12Z)-nonadeca-9,12-dienoyl]amino]tetradeca-4,8-diene-1-sulfonic acid
(4E,8E)-3-hydroxy-2-[[(11Z,14Z)-icosa-11,14-dienoyl]amino]trideca-4,8-diene-1-sulfonic acid
3-hydroxy-2-[[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]amino]tridecane-1-sulfonic acid
2-[[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]amino]-3-hydroxyundecane-1-sulfonic acid
(4E,8E,12E)-3-hydroxy-2-[[(Z)-nonadec-9-enoyl]amino]tetradeca-4,8,12-triene-1-sulfonic acid
(4E,8E,12E)-2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxyheptadeca-4,8,12-triene-1-sulfonic acid
(4E,8E,12E)-3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]icosa-4,8,12-triene-1-sulfonic acid
(E)-3-hydroxy-2-[[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]amino]tridec-4-ene-1-sulfonic acid
(4E,8E)-2-[[(9Z,12Z)-heptadeca-9,12-dienoyl]amino]-3-hydroxyhexadeca-4,8-diene-1-sulfonic acid
2-[[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]amino]-3-hydroxyheptadecane-1-sulfonic acid
(E)-3-hydroxy-2-[[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]amino]pentadec-4-ene-1-sulfonic acid
2-Amino-3-[hydroxy-(2-undecanoyloxy-3-undecoxypropoxy)phosphoryl]oxypropanoic acid
2-Amino-3-[(2-decanoyloxy-3-dodecoxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
2-Amino-3-[(3-decoxy-2-dodecanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
2-Amino-3-[(3-docosanoyloxy-2-hydroxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
4-[3-butanoyloxy-2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-propanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-hexanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-pentanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-acetyloxy-2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-heptanoyloxy-2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-[(E)-dodec-5-enoyl]oxy-2-[(E)-undec-4-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-[(6E,9E)-dodeca-6,9-dienoyl]oxy-2-undecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(E)-dodec-5-enoyl]oxy-3-[(E)-undec-4-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(E)-dec-4-enoyl]oxy-3-[(E)-tridec-8-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-tridecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-[(E)-dec-4-enoyl]oxy-2-[(E)-tridec-8-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(6E,9E)-dodeca-6,9-dienoyl]oxy-3-undecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(4E,7E)-deca-4,7-dienoyl]oxy-3-tridecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate
2-[hydroxy-[(E)-3-hydroxy-2-[[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]amino]oct-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
1-(2-methoxy-tetracosanyl)-sn-glycero-3-phosphoethanolamine
20-oxo-5-O-beta-mycaminosyltylactone
A macrolide antibiotic that is 20-oxotylactone having a beta-D-mycaminosyl residue attached at position 5.
Thiomyristoyl
Thiomyristoyl is a potent and specific SIRT2 inhibitor with an IC50 of 28 nM.